OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum sHLA‐G levels: A useful indicator in distinguishing colorectal cancer from benign colorectal diseases
Cheng‐Bao Zhu, C.-X. Wang, Xin Zhang, et al.
International Journal of Cancer (2010) Vol. 128, Iss. 3, pp. 617-622
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341

The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190

The role of classical and non-classical HLA class I antigens in human tumors
Juergen Bukur, Simon Jasinski, Barbara Seliger
Seminars in Cancer Biology (2012) Vol. 22, Iss. 4, pp. 350-358
Closed Access | Times Cited: 160

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133

Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8

Plasma soluble HLA‐G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer
Ming Cao, Shang-mian Yie, J. Liu, et al.
Tissue Antigens (2011) Vol. 78, Iss. 2, pp. 120-128
Closed Access | Times Cited: 101

Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients
Zhangyan Guo, Yonggang Lv, Lei Wang, et al.
Cellular Immunology (2014) Vol. 293, Iss. 1, pp. 10-16
Closed Access | Times Cited: 89

The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases
Fabrício C. Dias, Erick C. Castelli, Cristhianna V. A. Collares, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 71

Human leukocyte antigen‐G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells
Lutao Du, Xiaoyan Xiao, Chuanxin Wang, et al.
Cancer Science (2011) Vol. 102, Iss. 7, pp. 1272-1280
Open Access | Times Cited: 76

Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced in Vitro by Combined 5-Aza-2′-Deoxycytidine and Interferon-γ Treatments
Isabela Jubé Wastowski, Renata Toscano Simões, Layale Yaghi, et al.
American Journal Of Pathology (2012) Vol. 182, Iss. 2, pp. 540-552
Open Access | Times Cited: 65

Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer
Mathilde Allard, Romain Oger, Virginie Vignard, et al.
PLoS ONE (2011) Vol. 6, Iss. 6, pp. e21118-e21118
Open Access | Times Cited: 61

Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma
Aifen Lin, Xia Zhang, Wenjun Zhou, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 6, pp. 1382-1390
Open Access | Times Cited: 58

Human leukocyte antigen-G in cancer: Are they clinically relevant?
Wei‐Hua Yan
Cancer Letters (2011) Vol. 311, Iss. 2, pp. 123-130
Closed Access | Times Cited: 58

Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease?
Angela Dardano, Roberta Rizzo, Antonio Polini, et al.
The Journal of Clinical Endocrinology & Metabolism (2012) Vol. 97, Iss. 11, pp. 4080-4086
Open Access | Times Cited: 39

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
Simon Jasinski-Bergner, Markus Eckstein, Helge Taubert, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18

Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection
Weiwu Shi, Aifen Lin, Dan‐Ping Xu, et al.
Human Immunology (2011) Vol. 72, Iss. 11, pp. 1068-1073
Closed Access | Times Cited: 38

HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment
Marica Garziera, Ettore Bidoli, Erika Cecchin, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0144000-e0144000
Open Access | Times Cited: 31

Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages
Chandra Kirana, Andrew Ruszkiewicz, Richard S. Stubbs, et al.
International Journal of Cancer (2017) Vol. 140, Iss. 11, pp. 2577-2586
Open Access | Times Cited: 31

Liquid biopsies in gastrointestinal malignancies: when is the big day?
Anthony Lopez, Kazuto Harada, Dılşa Mızrak Kaya, et al.
Expert Review of Anticancer Therapy (2017) Vol. 18, Iss. 1, pp. 19-38
Closed Access | Times Cited: 31

Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy.
Xeni Provatopoulou, Eleni Kalogera, Alexandros Sagkriotis, et al.
PubMed (2012) Vol. 32, Iss. 3, pp. 1021-6
Closed Access | Times Cited: 32

The emerging role of soluble HLA-G in the control of chemotaxis
Fabio Morandi, Nathalie Rouas‐Freiss, Vito Pistoia
Cytokine & Growth Factor Reviews (2014) Vol. 25, Iss. 3, pp. 327-335
Closed Access | Times Cited: 27

The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer
Mónica Cavia-Sáiz, Pilar Múñiz, Beatriz Llorente Ayala, et al.
Molecular Biology Reports (2014) Vol. 41, Iss. 4, pp. 2275-2279
Closed Access | Times Cited: 27

Tumor border sharpness correlates with HLA-G expression in low-grade gliomas
Yinyan Wang, Xing Fan, Hongmin Li, et al.
Journal of Neuroimmunology (2015) Vol. 282, pp. 1-6
Closed Access | Times Cited: 25

Association of the HLA‐G 3′UTR polymorphisms with colorectal cancer in Italy: a first insight
Marica Garziera, Eulalia Catamo, Sérgio Crovella, et al.
International Journal of Immunogenetics (2015) Vol. 43, Iss. 1, pp. 32-39
Closed Access | Times Cited: 21

HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer
Antonio David Lazaro Sanchez, P. Salces-Ortiz, Laura Velásquez, et al.
Clinical & Translational Oncology (2019) Vol. 22, Iss. 7, pp. 1166-1171
Closed Access | Times Cited: 21

Page 1 - Next Page

Scroll to top